2 recruiting, 1 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Recruiting 2, Completed 1 |
Follow Transarterial Chemoembolization: new trials by email Literature Review of Transarterial Chemoembolization trials Research Report on Transarterial Chemoembolization
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adjuvant TACE in HCC With High-risk Recurrence Factors Adjuvant transarterial chemoembolization, Intensive follow-up - Hepatocellular Carcinoma, Adjuvant | Phase 3 | Recruiting | Guangxi Medical University | 442 | 2026-02-01 | 2026-02-18 |
| TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma TACE plus camrelizumab and apatinib, Camrelizumab and apatinib - Unresectable Hepatocellular Carcinoma, Transarterial Chemoembolization | Phase 3 | Recruiting | Guohui Xu | 101 | 2024-08-10 | 2026-04-14 |
| TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular Carcinoma TACE+sorafenib, TACE - Hepatocellular Carcinoma, Sorafenib | Phase 3 | Completed | Sun Yat-sen University | 162 | 2019-10-02 | 2024-02-28 |
Adenocarcinoma (2) · Carcinoma (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Liver Diseases (2) · Liver Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2)
apatinib (1) · camrelizumab (1)
Guangxi Medical University (1) · Guohui Xu (1) · Sun Yat-sen University (1)
China (3)
Guohui Xu (1) · Jian-Hong Zhong (1) · Ming Kuang, PhD (1)